Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 31, Issue 5, 2002, Pages 521-528

  O'Connell, Jacqueline M ^a   Hogg, Robert S ^a,g   Chan, Keith ^a   Strathdee, Steffanie A ^b   McLean, Nancy ^d   Martindale, Steve L ^e   Willoughby, Brian ^f   Remis, Robert ^c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d Vanvax The Vancouver Vaccine Trial   (Canada)

^e Vanguard Project   (Canada)

^f Spectrum Health   (Canada)

^g BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

Author keywords

AIDSVAX B B; Gay and bisexual men; Phase 3 trial; Population based cohort; Preventive HIV vaccine; Willingness to participate

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BISEXUALITY; CANADA; CLINICAL TRIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFORMED CONSENT; MALE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALITY;

EID: 0037114815     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200212150-00010     Document Type: Article

References (24)

1. Birmingham K. HIV vaccines and the winner is. Nat Med 1998;4:753.
2. AIDSVAX. Phase III Clinical Trials of AIDSVAX. Available at: http://vaxgen.com/vaccine.htm. 2000.
3. Koblin BA, Holte S, Lenderking B, et al. Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team. J Acquir Immune Defic Syndr 2000;24:451-7.
4. Buchbinder SP, Douglas JM Jr, McKirnan DJ, et al. Feasibility of human immunodeficiency virus vaccine trials in homosexual men in the United States: Risk behavior, seroincidence, and willingness to participate. J Infect Dis 1996;174:954-61.
5. Strathdee S, Hogg R, Cornelisse P, et al. Factors associated with willingness to participate in HIV vaccine trials among HIV-negative injection drug users and young gay and bisexual men. AIDS and Behavior 2000;4:271-8.
6. Rida W, Fast P, Hoff R, et al. Intermediate-size trials for the evaluation of HIV vaccine candidates: A workshop summary. J Acquir Immune Defic Syndr 1997;16:195-203.
7. Gross M, Seage GR, Mayer KH, et al. Interest among gay/bisexual men in greater Boston in participating in clinical trials of preventive HIV vaccines. J Acquir Immune Defic Syndr 1996;12:406-12.
8. Koblin BA, Heagerty P, Sheon A, et al. Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS 1998;12:785-93.
9. Bartholow BN, MacQueen KM, Douglas JM Jr, et al. Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men. J Acquir Immune Defic Syndr 1997;16:108-15.
10. Hays RB, Kegeles SM. Factors related to the willingness of young gay men to participate in preventive HIV vaccine trials. J Acquir Immune Defic Syndr 1999;20:164-71.
11. Strathdee SA, Hogg RS, Martindale SL, et al. Determinants of sexual risk-taking among young HIV-negative gay and bisexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;19:61-6.
12. Mirowsky J, Ross CE. Age and depression. J Health Soc Behav 1992;33:187-205; discussion 206-12.
13. Van de Ven P, Kippax S, Knox S, et al. HIV treatments optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS 1999;13:2289-94.
14. Koblin BA, Avrett S, Taylor PE, et al. Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE. J Acquir Immune Defic Syndr Hum Retrovirol 1997;15:165-71.
15. Chesney MA, Chambers DB, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: A cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol 1997;16:266-71.
16. Katz MH. AIDS epidemic in San Francisco among men who report sex with men: Successes and challenges of HIV prevention. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14(suppl 2): S38-46.
17. Ostrow D, McKirnan D. Prevention of substance-related high-risk sexual behaviour among gay men: Critical review of the literature and proposed harm reduction approach. Journal of the Gay and Lesbian Medical Association 1997;1:97-110.
18. Scheer S, Douglas JM Jr, Vittinghoff E, et al. Feasibility and suitability of targeting young gay men for HIV vaccine efficacy trials. J Acquir Immune Defic Syndr 1999;20:172-8.
19. Strathdee SA, Martindale SL, Cornelisse PG, et al. HIV infection and risk behaviours among young gay and bisexual men in Vancouver. CMAJ 2000;162:21-5.
20. Vlahov D, Astemborski J, Solomon L, et al. Interest in HIV vaccines among injection drug users in Baltimore, Maryland. AIDS Res Hum Retroviruses 1994;10(suppl 2):S265-8.
21. Meyers K, Metzger DS, Navaline H, et al. HIV vaccine trials: Will intravenous drug users enroll? Am J Public Health 1994;84:761-6.
22. Catania JA, Coates TJ, Stall R, et al. Changes in condom use among homosexual men in San Francisco. Health Psychol 1991;10:190-9.
23. Davidovich U, de Wit JB, Stroebe W. Assessing sexual risk behaviour of young gay men in primary relationships: The incorporation of negotiated safety and negotiated safety compliance. AIDS 2000;14:701-6.
24. Strauss RP, Sengupta S, Kegeles S, et al. Willingness to volunteer in future preventive HIV vaccine trials: Issues and perspectives from three U.S. communities. J Acquir Immune Defic Syndr 2001;26:63-71.